Drug, Healthcare and Patient Safety
Overview
Drug, Healthcare and Patient Safety is a scientific journal, published by Dove Medical Press since 2009 in English. The journal's country of origin is New Zealand and its primary focus area is health services.
Details
Details
Abbr.
Drug Healthc Patient Saf
Publisher
Dove Medical Press
Start
2009
End
Continuing
e-ISSN
1179-1365
Country
New Zealand
Language
English
Specialty
Health Services
Metrics
Metrics
h-index / Ranks: 10441
30
SJR / Ranks: 7905
571
CiteScore / Ranks: 9809
2.40
Recent Articles
11.
12.
Chiumia F, Chimimba F, Nyirongo H, Kampira E, Muula A, Khuluza F
Drug Healthc Patient Saf
. 2024 Jul;
16:89-101.
PMID: 39070704
Objective: We aimed to assess the occurrence and characteristics of antibiotic-associated adverse drug reactions (ADRs) in Malawi. Methods: We retrospectively reviewed 304 patient records from medical wards in three hospitals...
13.
Gebremariam S, Sema F, Jara A, Mekonnen G
Drug Healthc Patient Saf
. 2024 Jul;
16:75-88.
PMID: 39050408
Background: Medication-related hospital admission (MRHA) is hospitalization due to drug-related problems. MRHAs have been reported to be on the rise in recent decades. Objective: This study was aimed at determining...
14.
Thomas F, Abiri O, Kallon J, Kangbai D, Conteh T, Conteh S, et al.
Drug Healthc Patient Saf
. 2024 Jun;
16:61-73.
PMID: 38911456
Background: The manifestation and spread of neuroinvasive circulating vaccine-derived polioviruses (cVDPVs) across several countries, which led to the emergency use of the novel oral polio vaccine type 2 (nOPV2), raised...
15.
Cassady S, Almario J, Ramani G
Drug Healthc Patient Saf
. 2024 Jun;
16:51-59.
PMID: 38855777
Pulmonary arterial hypertension (PAH) is a complex and incurable disease for which pulmonary vasodilators remain the core therapy. Of the three primary pathways that vasodilators target, the prostacyclin pathway was...
16.
Al Qamariat Z, Aljaffar A, Alabdulaal Z, Alnezir F, Al-Zawad W, Alqattan M, et al.
Drug Healthc Patient Saf
. 2024 May;
16:43-49.
PMID: 38800628
Introduction: Thrombocytopenia is a common and potentially severe adverse effect of linezolid, but the time to onset during treatment has varied substantially across studies. Moreover, the time to recovery after...
17.
Stasiak M, Witek P, Adamska-Fita E, Lewinski A
Drug Healthc Patient Saf
. 2024 Apr;
16:35-42.
PMID: 38616817
Cushing's disease (CD) is the most common cause of endogenous hypercortisolism. Osilodrostat was demonstrated to be efficient in treating CD, and the mean average dose required for CD control was...
18.
Tang W, Zhou W, Zheng X
Drug Healthc Patient Saf
. 2024 Mar;
16:29-33.
PMID: 38476932
Obstructive fibrinous tracheal pseudomembrane (OFTP) is a relatively rare complication of endotracheal intubation. Despite being well documented, the exact pathogenesis of OFTP remains unclear. Some studies suggest that it may...
19.
Flatie Alemu A, Tegegne A, Getaw N
Drug Healthc Patient Saf
. 2024 Feb;
16:19-28.
PMID: 38318121
Background: WHO estimates that 15.8% of substandard or falsified medical products are used to treat non-communicable diseases which account for 80% of the global burden including diabetes. The increased level...
20.
Andresen K, Hinojosa-Campos M, Podmore B, Drysdale M, Qizilbash N, Cunnington M
Drug Healthc Patient Saf
. 2024 Jan;
16:1-17.
PMID: 38192299
Introduction: Regulatory guidance encourages transparent reporting of information on the quality and validity of electronic health record data being used to generate real-world benefit-risk evidence for vaccines and therapeutics. We...